In a recent breakthrough in cancer research, a new online tool has enhanced communication between patients and clinical researchers, aiming to make clinical trials feel less overwhelming. By fostering a more supportive environment, this tool could pave the way for more individuals to participate in important health studies.

The Participant Engagement Portal (PEP)

The Participant Engagement Portal, known as PEP, was developed by the Alliance for Clinical Trials in Oncology. This tool aims to create a direct link between researchers and patients involved in clinical studies. It allows users to share important information, stay updated on their trials, and report on various social factors affecting their health.

In a pilot project, 84% of participants reported a positive experience using PEP. Dr. Norah Crossnohere, the lead author of the study, noted that the portal was designed with input from both patients and advocates. Its goal is to treat participants as essential partners in the research process, not just data points in a study.

User Experience and Feedback

The usability statistics for PEP are impressive. A whopping 96% of participants found it easy to access, while 93% reported that completing surveys was also straightforward. Many patients expressed interest in being contacted for future research opportunities, with 93% willing to participate again.

The pilot project included participants from the Multi-Cancer Early Detection Biobank Study, which focuses on potential blood tests for early cancer detection. Among 2,221 individuals in this national trial, around 40% opted to use PEP, demonstrating its appeal.

The project revealed critical insights about patient needs and behaviors. For instance, the portal effectively gathered data on important social determinants of health—factors like education, housing stability, and financial concerns—which can inform treatment outcomes. Participants also showed a high willingness to share personal data securely, indicating a level of trust in the platform.

Innovative Features of PEP

PEP stands out because it facilitates two-way communication between researchers and participants. Traditional clinical trial communication often flows one way, from the researchers to the participants. PEP changes this dynamic by enabling researchers to send newsletters and study updates directly, empowering patients with information.

Access to the portal is password-free, eliminating barriers that often frustrate users. Instead of a traditional login, patients receive a unique web link via text or email, simplifying their interaction with the platform.

Importantly, PEP also prioritizes accessibility. Designed with the guidance of healthcare providers and patient advocates, it eliminates complex medical jargon and uses plain language. Furthermore, the content is available in both English and Spanish, tailored for cultural relevance.

Looking to the Future

While the PEP pilot has seen great success, researchers recognize the need to diversify their participant pool. Feedback indicated that the platform attracted more females and fewer ethnic minorities compared to the overall study group. Plans are in place to create educational resources for clinical personnel, aiming to expand the use of PEP in more national trials.

According to Nancy Campbell, a co-author of the study and Associate Director of Operations at the Alliance Data Innovation Lab, PEP serves as a scalable model to improve transparency and collaboration in clinical trials. This tool is a step towards making research more inclusive and effective for everyone involved.

What this means for you

As the healthcare landscape continues to modernize, tools like PEP show promise for enhancing patient involvement in clinical trials. If you ever need to review medical consent documents or patient agreements, legal-document-to-plain-english-translator/”>AI legalese decoder can help translate them into plain English in seconds. By staying informed about your rights and options in healthcare, you can make better decisions for yourself and your family.

Source: https://ascopost.com/news/june-2026/digital-tool-may-improve-patient-engagement-in-oncology-clinical-trials/